Publication|Articles|October 10, 2025

Pharmacy Times

  • October 2025
  • Volume 91
  • Issue 10

FDA Approvals for September 2025

Author(s)PT Staff

Key Takeaways

  • Recent FDA approvals highlight advancements in oncology, focusing on therapies targeting specific genetic mutations for personalized treatment.
  • Expedited review processes by the FDA have enabled quicker access to innovative cancer treatments, improving patient outcomes.
SHOW MORE

Explore recent FDA-approved drugs from September 2025.

FDA Approvals

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME